Geron | GERN - Assets

Geron reported $232.61M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Amgen AMGN:US USD 65.12B 1.42B
Bio Techne TECH:US USD 2.36B 12.68M
Cti Biopharma CTIC:US USD 125.92M 2.46M
Cytokinetics CYTK:US USD 1.01B 61.19M
Esperion Therapeutics ESPR:US USD 247.94M 64.89M
Exelixis EXEL:US USD 3.07B 110.12M
Genmab GEN:DC DKK 30.28B 408M
Gilead Sciences GILD:US USD 63.17B 614M
Macrogenics MGNX:US USD 280.47M 85.12M
Novartis NOVN:VX USD 117.45B 1.01B
Novavax NVAX:US USD 2.26B 8.76M
Pain Therapeutics PTIE:US USD 234.83M 27.55M
Seattle Genetics SGEN:US USD 3.67B 55.45M
YTE INCY:US USD 5.84B 330.77M